Chinese blood plasma is "cleansed" as authorities issue conflicting messages about HIV infection



[ad_1]

Chinese authorities have made contradictory statements about human blood plasma treatments that have been found to be contaminated with HIV. The country's drug badyst said he canceled treatments just a day after his national health authorities announced they were defective.

National Medical Products Administration (NMPA) inspectors said Wednesday that samples from a batch of 12,229 bottles of intravenous immunoglobulin were free of HIV and hepatitis B and C.

The lottery's approval, produced by Shanghai Xinxing Pharmaceutical Company, contradicts the National Health Commission's announcement of its contamination and urges hospitals to suspend treatment immediately. .

The provincial health commission and the disease control center of Jiangxi Province, in eastern China, had detected traces of HIV in the lot, although the disease control center Beijing news Wednesday, he had not yet discovered cases of patients who contracted HIV.

12,000 treatments of Chinese blood plasma contaminated with HIV

The batch of 50 ml flasks is due to expire in June 2021, said a source from the state's food and drug regulatory authority. China Business Journal.

Immunoglobulins are antibodies produced by white blood cells used to treat immune deficiencies caused by diseases such as leukemia, hepatitis and rabies.

The NMPA – which was at the center of a major rabies vaccine scandal last July – immediately ordered the Shanghai control authorities to carry out on-site inspections at the pharmaceutical company and sent officials to Jiangxi, announced Wednesday the newspaper.

At the same time, the Shanghai regulator said in a separate statement that it had stopped production in the company, recalled all the affected treatments and sent samples for inspection.

China sanctions more than 80 officials linked to major vaccines scandal

The latest blow to confidence in China's health services comes less than a month after the revelation that 145 children in Jiangsu province in the east of the country had been treated with outdated polio vaccines, sparking many protests from their parents and the investigation of 17 local officials.

In July, 252,600 defective rabies vaccines manufactured by Changchun Changsheng Bio-technology, one of the largest vaccine companies in the country, were administered to thousands of toddlers.

In the 1990s, thousands of cash – strapped villagers in central China 's Henan Province contracted HIV after being persuaded to sell their blood illegally on the black market.

Henan: 1 in 8 who sold blood have HIV

The rapid spread of blood-borne diseases, such as HIV and hepatitis B, was due to needle reuse, lack of disease screening, false medical records, and blood mixing before reinjecting to the donors the separated red blood cells.

A study of 280,000 Henan villagers who sold their blood found that more than 36,000 people – about one in eight – were HIV-positive or have AIDS.

The apparent clearance of blood plasma treatments by the NMPA on Wednesday came four days after Wu Zhen, the former deputy chief of the CFDA (Food and Drug Administration), who oversees the NMPA, was handed over to the judicial system for investigation by the communist government. Anti-corruption observatory of the party in the context of the rabies vaccine scandal. Wu, one of four CFDA officials being investigated, was responsible for China's regulations on vaccines at the time.

While a new scandal about a vaccine hits China, parents say that they have lost confidence in the system

The official Xinhua news agency said the charges against Wu included nepotism and bribes.

Changchun Changsheng Biotechnology was fined 9.1 billion yuan (1.3 billion US dollars) in October after discovering that she had made records. The authorities did not act immediately after finding inconsistencies in the company's records at the end of 2017.

[ad_2]
Source link